Roth Conference company presentations begin this morning. We'll be watching 3 biotechs: TCON, CUR and ATNM.
Existing Home Sales fell 0.9% in February to an annual rate of 4.59 million homes, weaker than expectations. The Dow Jones Industrial Average traded between 13,158.11 and 13,190.02 in the opening
Company chart and information is provided by TradingView based on 15-minute-delayed data.
TRACON Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer and utilizing its cost efficient, contract research organization (CRO) independent product development platform to partner with ex-U.S. companies to develop and commercialize innovative products in the United States. The company's drug candidate includes Envafolimab, TRC102, TRC253, TJ4309, Bispecific Antibodies.
| Website: | www.traconpharma.com |
| Email: | mwiggins@traconpharma.com |
| Main Phone: | +1 858 550-0780 |
| Address: | 4350 La Jolla Village Drive |
| Address 2: | Suite 800 |
| State: | CA |
| City / Town: | San Diego |
| Country: | US |
| Postal Code: | 92122 |
| Exchange: | NSC |
| CEO: | Charles P. Theuer |
| Employees: | 18 |
| NAICS: | Medicinal and Botanical Manufacturing(325411) |
Roth Conference company presentations begin this morning. We'll be watching 3 biotechs: TCON, CUR and ATNM.
Existing Home Sales fell 0.9% in February to an annual rate of 4.59 million homes, weaker than expectations. The Dow Jones Industrial Average traded between 13,158.11 and 13,190.02 in the opening
| Last Price N/A | Change $ N/A | Change % N/A | Tick N/A |
| Bid N/A | Bid Size N/A | Ask N/A | Ask Size N/A |
| Open N/A | High N/A | Low N/A | Prev Close N/A |
| Last Trade | Volume N/A | 52 Wk Hi N/A | 52 Wk Low N/A |
| Market Cap N/A | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
| Shares N/A | EPS (TTM) N/A | PE Ratio N/A | Exchange N/A |
© 2022 Equities News | Equities.com, Inc.
* All dates and time are being displayed in Eastern Standard Time (EST).
